Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BROADRIDGE FINANCIAL SOLUTIONS, INC.BR · Entity 3252 | Director | October 03, 2024 | October 07, 2024 |
| CORNING INC /NYGLW · Entity 2883 | Director | February 11, 2026 | February 12, 2026 |
| Hewlett Packard Enterprise CoHPE · Entity 2984 | Director | May 04, 2018 | May 08, 2018 |
| Merck & Co., Inc.MRK · Entity 2807 | Director | May 28, 2021 | June 02, 2021 |
| Thoma Bravo AdvantageTBA · Entity 143669 | Director | January 13, 2021 | January 14, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BROADRIDGE FINANCIAL SOLUTIONS, INC.
Report date October 03, 2024 · Filed October 07, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 77,433 |
Reported balance
After 2024-10-03 transaction · row 1
1 source rowRow 1 · 2024-10-03 · Grant · Acquired 115 · Balance 77,433 F1: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.
CORNING INC /NY
Report date February 11, 2026 · Filed February 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 44,218 |
Reported balance
After 2026-02-11 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-02-11 · Grant · Acquired 1,806 · Balance 44,218 F3: Represents annual equity retainer in the form of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Corning Incorporated common stock. F2: Conversion of restricted stock units to the Company's common stock and distribution of such stock is deferred until a specific date as elected by the participant or termination of service as a Corning director. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 977 |
Reported balance
Holding disclosure · report date 2026-02-11 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 977 F1: Each restricted stock unit represents a contingent right to receive one share of Corning Incorporated common stock. F2: Conversion of restricted stock units to the Company's common stock and distribution of such stock is deferred until a specific date as elected by the participant or termination of service as a Corning director. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 1,663 |
Reported balance
Holding disclosure · report date 2026-02-11 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 1,663 F1: Each restricted stock unit represents a contingent right to receive one share of Corning Incorporated common stock. F2: Conversion of restricted stock units to the Company's common stock and distribution of such stock is deferred until a specific date as elected by the participant or termination of service as a Corning director. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2026-02-11 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Corning Incorporated common stock.
F2: Conversion of restricted stock units to the Company's common stock and distribution of such stock is deferred until a specific date as elected by the participant or termination of service as a Corning director.
F3: Represents annual equity retainer in the form of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Corning Incorporated common stock.
Hewlett Packard Enterprise Co
Report date May 04, 2018 · Filed May 08, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 12,493 |
Reported balance
After 2018-05-04 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-05-04 · Grant · Acquired 12,493 · Balance 12,493 F3: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F4: On 05/04/18, the reporting person was granted 12,493 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/04/19 or the date of Issuer's 2019 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The RSUs that cliff vest will be deferred as noted in footnote (2) above. |
| Common StockSEC Table I · non-derivative | Direct | 18,847 |
Reported balance
Holding disclosure · report date 2018-05-04 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 18,847 F1: There is no reportable change since the last filing. This is a reiteration of holdings only. |
| Common StockSEC Table I · non-derivative | IndirectBy Merrill Lynch | 15,416.8193 |
Reported balance
Holding disclosure · report date 2018-05-04 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 15,416.8193 F2: The reporting person elected to defer the receipt of these shares of common stock until termination of his service as a member of the Issuer's Board of Directors. Included in Column 5 are 65.81930 DEUs reflecting an adjustment in DEU incremental value. |
Filing footnotes · ownership attribution and instrument terms
F1: There is no reportable change since the last filing. This is a reiteration of holdings only.
F2: The reporting person elected to defer the receipt of these shares of common stock until termination of his service as a member of the Issuer's Board of Directors. Included in Column 5 are 65.81930 DEUs reflecting an adjustment in DEU incremental value.
F3: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
F4: On 05/04/18, the reporting person was granted 12,493 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/04/19 or the date of Issuer's 2019 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The RSUs that cliff vest will be deferred as noted in footnote (2) above.
Merck & Co., Inc.
Report date May 28, 2021 · Filed June 02, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 49,719.0553 |
Reported balance
After 2021-05-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-05-28 · Grant · Acquired 2,635.3933 · Balance 49,719.0553 F1: 1-for-1 F2: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3: Holdings include shares acquired in dividend reinvestment transactions. |
| Common StockSEC Table I · non-derivative | Direct | 1,948 |
Reported balance
Holding disclosure · report date 2021-05-28 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,948 |
Filing footnotes · ownership attribution and instrument terms
F1: 1-for-1
F2: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
F3: Holdings include shares acquired in dividend reinvestment transactions.
Thoma Bravo Advantage
Report date January 13, 2021 · Filed January 14, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B ordinary sharesSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-01-13 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: As described in the issuer's registration statement on Form S-1 (File No. 333-251772) under the heading "Description of Securities--Founder Shares," the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments, and have no expiration date. Includes 2,500,000 Class B ordinary shares that are subject to forfeiture if the underwriter of the issuer's initial public offering does not exercise in full its option to purchase additional Class A ordinary shares. |
Filing footnotes · ownership attribution and instrument terms
F1: As described in the issuer's registration statement on Form S-1 (File No. 333-251772) under the heading "Description of Securities--Founder Shares," the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments, and have no expiration date. Includes 2,500,000 Class B ordinary shares that are subject to forfeiture if the underwriter of the issuer's initial public offering does not exercise in full its option to purchase additional Class A ordinary shares.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CDK Global, Inc.
Report date July 06, 2022 · Filed July 06, 2022
Section 16 reporting ended · disclosed 2022-07-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 1
1 source rowRow 1 · 2022-07-06 · Disposition to issuer · Disposed 61,762 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), among the Company, Central Parent LLC ("Parent") and Central Merger Sub Inc. ("Merger Sub"), on July 6, 2022, Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"), and, at the effective time of the Merger, each share of common stock, par value $0.01 per share (each, a "Share"), of the Company was canceled and converted into the right to receive $54.87 in cash without interest. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.67 | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-07-06 · Disposition to issuer · Disposed 15,384 · Balance 0 F2: Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Merger, whether then unvested or vested, by virtue of the Merger and without any action by the holder, was canceled and converted into only the right to receive an amount in cash, without interest, equal to the product of (x) the number of Shares issuable under such option and (y) the excess, if any, of (i) $54.87 over (ii) the exercise price payable in respect of each Share issuable under such option (the "Option Consideration"); provided, however, that the Option Consideration for each option with an exercise price equal to or greater than $54.87 was $0. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), among the Company, Central Parent LLC ("Parent") and Central Merger Sub Inc. ("Merger Sub"), on July 6, 2022, Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"), and, at the effective time of the Merger, each share of common stock, par value $0.01 per share (each, a "Share"), of the Company was canceled and converted into the right to receive $54.87 in cash without interest.
F2: Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Merger, whether then unvested or vested, by virtue of the Merger and without any action by the holder, was canceled and converted into only the right to receive an amount in cash, without interest, equal to the product of (x) the number of Shares issuable under such option and (y) the excess, if any, of (i) $54.87 over (ii) the exercise price payable in respect of each Share issuable under such option (the "Option Consideration"); provided, however, that the Option Consideration for each option with an exercise price equal to or greater than $54.87 was $0.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2018 Filed Feb 15, 2018 09:38 UTC | BROADRIDGE FINANCIAL SOLUTIONS, INC. BR · Entity 3252 | SaleCommon Stock | 7,058 | $95.24 | $672,194.74 |
DisclosureSEC source: 0001225208-18-002969 · doc4.xml · nonDerivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,788 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.18 - $95.33, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 09:38 UTC | BROADRIDGE FINANCIAL SOLUTIONS, INC. BR · Entity 3252 | Exercise / conversionCommon Stock | 12,600 | $18.96 | $238,896.00 |
DisclosureSEC source: 0001225208-18-002969 · doc4.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,846 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2018 Filed Jan 4, 2018 12:23 UTC | BROADRIDGE FINANCIAL SOLUTIONS, INC. BR · Entity 3252 | GrantCommon Stock | 83 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000538 · doc4.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,246 F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 16, 2017 Filed Nov 20, 2017 15:13 UTC | BROADRIDGE FINANCIAL SOLUTIONS, INC. BR · Entity 3252 | GrantStock Option (Right to Buy) · Derivative | 5,735 | $0.00 Strike: $88.66 | $0.00 |
DisclosureSEC source: 0001225208-17-017508 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,735 Underlying: Common Stock · 5,735 shares Expires 2027-11-16 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 16, 2017 Filed Nov 20, 2017 15:13 UTC | BROADRIDGE FINANCIAL SOLUTIONS, INC. BR · Entity 3252 | GrantCommon Stock | 1,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-017508 · doc4.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,163 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 17:16 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 1,138 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-17-002062 · es1701148_4-brun.xml · nonDerivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,361 F3 · shares: The reported transaction reflects the grant of Deferred Stock Units under the Issuer's 2014 Omnibus Award and represents a like number of shares of the Issuer's common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of the Issuer's common stock. F2 · balance_after: Since the date of the reporting person's last ownership report, Mr. Brun transferred 757 shares of common stock of CDK Global, Inc. to his former spouse pursuant to a domestic relation order. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 17:16 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 2,467 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-17-002062 · es1701148_4-brun.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,223 F1 · shares: The reported transaction reflects the grant of Restricted Stock Units under the Issuer's 2014 Omnibus Award Plan and represents a like number of shares of the Issuer's common stock. These Restricted Stock Units vest in full at the earlier of November 15, 2018 and the Issuer's next annual meeting of stockholders. Upon vesting these Restricted Stock Units will be deferred and settled in shares of the Issuer's common stock 180 days after the date the Reporting Person ceases to be a member of the Issuer's board of directors. F2 · balance_after: Since the date of the reporting person's last ownership report, Mr. Brun transferred 757 shares of common stock of CDK Global, Inc. to his former spouse pursuant to a domestic relation order. Read SEC document |
| October 03, 2017 Filed Oct 4, 2017 12:20 UTC | BROADRIDGE FINANCIAL SOLUTIONS, INC. BR · Entity 3252 | GrantCommon Stock | 86 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-015890 · doc4.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,958 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| July 05, 2017 Filed Apr 2, 2018 23:36 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | GrantRestricted Stock Units · Derivative | 189.3044 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179706-18-000037 · edgar.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,350.9541 Underlying: Common Stock · 189.3044 shares Expires not disclosed F2 · security: As reported in the Registration Statements on Form 10 filed by Issuer with the SEC, in connection with the spin-offs of Everett SpinCo, Inc. on 04/01/17 and Seattle SpinCo, Inc. on 09/01/17, equity-based awards granted by Issuer, prior to the spin-offs were converted to adjust the award in a manner intended to preserve the aggregate intrinsic value of the original award as measured immediately before and immediately after the spin-offs, subject to rounding. The adjusted equity award is otherwise subject to the same terms and conditions that applied to the original award immediately prior to the spin-offs, unless otherwise noted. The reporting person's equity based awards reflect the conversion adjustments. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F4 · shares: As previously reported, on 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.The 189.3044 dividend equivalent rights being reported reflect 45.4808 dividend equivalent rights at $16.94 per RSU credited to the reporting person's account on 07/05/17, 66.5328 dividend equivalent rights at $14.80 per RSU credited to the reporting person's account on 10/04/17, and 77.2908 dividend equivalent rights at $14.70 per RSU credited to the reporting person's account on 01/03/18. Unvested RSUs in this footnote, and the amount in column 9 reflect the conversion adjustment noted in footnote (2) above. F4 · price: As previously reported, on 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.The 189.3044 dividend equivalent rights being reported reflect 45.4808 dividend equivalent rights at $16.94 per RSU credited to the reporting person's account on 07/05/17, 66.5328 dividend equivalent rights at $14.80 per RSU credited to the reporting person's account on 10/04/17, and 77.2908 dividend equivalent rights at $14.70 per RSU credited to the reporting person's account on 01/03/18. Unvested RSUs in this footnote, and the amount in column 9 reflect the conversion adjustment noted in footnote (2) above. F4 · derivative.exercise_date: As previously reported, on 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.The 189.3044 dividend equivalent rights being reported reflect 45.4808 dividend equivalent rights at $16.94 per RSU credited to the reporting person's account on 07/05/17, 66.5328 dividend equivalent rights at $14.80 per RSU credited to the reporting person's account on 10/04/17, and 77.2908 dividend equivalent rights at $14.70 per RSU credited to the reporting person's account on 01/03/18. Unvested RSUs in this footnote, and the amount in column 9 reflect the conversion adjustment noted in footnote (2) above. F4 · derivative.expiration_date: As previously reported, on 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.The 189.3044 dividend equivalent rights being reported reflect 45.4808 dividend equivalent rights at $16.94 per RSU credited to the reporting person's account on 07/05/17, 66.5328 dividend equivalent rights at $14.80 per RSU credited to the reporting person's account on 10/04/17, and 77.2908 dividend equivalent rights at $14.70 per RSU credited to the reporting person's account on 01/03/18. Unvested RSUs in this footnote, and the amount in column 9 reflect the conversion adjustment noted in footnote (2) above. Read SEC document |
| July 03, 2017 Filed Jul 6, 2017 11:02 UTC | BROADRIDGE FINANCIAL SOLUTIONS, INC. BR · Entity 3252 | GrantCommon Stock | 84 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-012324 · doc4.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,872 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. F2 · balance_after: Since the date of the reporting person's last ownership report, Mr. Brun transferred 568 shares of common stock of Broadridge Financial Solutions, Inc. to his former spouse pursuant to a domestic relations order. Read SEC document |
| May 26, 2017 Filed May 30, 2017 21:33 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 2,618.6075 | $64.92 | $170,000.00 |
DisclosureSEC source: 0001225208-17-010551 · doc4.xml · derivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,271.3795 Underlying: Common Stock · 2,618.6075 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| April 21, 2017 Filed Apr 26, 2017 01:00 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | GrantRestricted Stock Units · Derivative | 11,853 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179706-17-000101 · edgar.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,853 Underlying: Common Stock · 11,853 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · shares: The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors. F4 · shares: On 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The RSUs that cliff vest will be deferred as noted in footnote (2) above. F4 · price: On 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The RSUs that cliff vest will be deferred as noted in footnote (2) above. F4 · derivative.exercise_date: On 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The RSUs that cliff vest will be deferred as noted in footnote (2) above. F4 · derivative.expiration_date: On 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The RSUs that cliff vest will be deferred as noted in footnote (2) above. Read SEC document |
| April 21, 2017 Filed Apr 26, 2017 01:00 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | GrantCommon Stock | 992 | $18.14 | $17,994.88 |
DisclosureSEC source: 0001179706-17-000101 · edgar.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,619 F1 · price: These shares were issued to the reporting person pursuant to the Issuer's 2015 Stock Incentive Plan in lieu of additional meeting fees of $18,000 for Issuer's Board Year 2016. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 12:25 UTC | BROADRIDGE FINANCIAL SOLUTIONS, INC. BR · Entity 3252 | GrantCommon Stock | 93 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-007241 · doc4.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,356 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| March 22, 2017 Filed Mar 23, 2017 23:51 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | Exercise / conversionRestricted Stock Units · Derivative | 10,253 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179706-17-000050 · edgar.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,253 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · shares: On 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested is an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 28.1870 dividend equivalent rights at $23.45 per RSU credited to the reporting person's account on 01/04/17. The number of derivative securities in column 5 includes 84 vested dividend equivalent rights and a de minimus adjustment of 0.5258 due to fractional rounding of the dividend equivalent rights. F2 · price: On 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested is an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 28.1870 dividend equivalent rights at $23.45 per RSU credited to the reporting person's account on 01/04/17. The number of derivative securities in column 5 includes 84 vested dividend equivalent rights and a de minimus adjustment of 0.5258 due to fractional rounding of the dividend equivalent rights. F2 · derivative.exercise_date: On 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested is an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 28.1870 dividend equivalent rights at $23.45 per RSU credited to the reporting person's account on 01/04/17. The number of derivative securities in column 5 includes 84 vested dividend equivalent rights and a de minimus adjustment of 0.5258 due to fractional rounding of the dividend equivalent rights. F2 · derivative.expiration_date: On 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested is an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 28.1870 dividend equivalent rights at $23.45 per RSU credited to the reporting person's account on 01/04/17. The number of derivative securities in column 5 includes 84 vested dividend equivalent rights and a de minimus adjustment of 0.5258 due to fractional rounding of the dividend equivalent rights. Read SEC document |
| March 22, 2017 Filed Mar 23, 2017 23:51 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | Exercise / conversionCommon Stock | 10,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001179706-17-000050 · edgar.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2017 Filed Apr 26, 2017 01:00 UTC Amendment | Hewlett Packard Enterprise Co HPE · Entity 2984 | Exercise / conversionRestricted Stock Units · Derivative | 13,499 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179706-17-000100 · edgar.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,499 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · shares: As previously reported, on 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested was an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. The number of RSUs reported in this amendment reflects that conversion adjustment. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 110 vested dividend equivalent rights and a de minimus adjustment of 0.5258 due to fractional rounding of the dividend equivalent rights. F2 · price: As previously reported, on 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested was an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. The number of RSUs reported in this amendment reflects that conversion adjustment. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 110 vested dividend equivalent rights and a de minimus adjustment of 0.5258 due to fractional rounding of the dividend equivalent rights. F2 · derivative.exercise_date: As previously reported, on 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested was an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. The number of RSUs reported in this amendment reflects that conversion adjustment. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 110 vested dividend equivalent rights and a de minimus adjustment of 0.5258 due to fractional rounding of the dividend equivalent rights. F2 · derivative.expiration_date: As previously reported, on 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested was an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. The number of RSUs reported in this amendment reflects that conversion adjustment. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 110 vested dividend equivalent rights and a de minimus adjustment of 0.5258 due to fractional rounding of the dividend equivalent rights. Read SEC document |
| March 22, 2017 Filed Apr 26, 2017 01:00 UTC Amendment | Hewlett Packard Enterprise Co HPE · Entity 2984 | Exercise / conversionCommon Stock | 13,499 | $0.00 | $0.00 |
DisclosureSEC source: 0001179706-17-000100 · edgar.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,627 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 13:56 UTC | BROADRIDGE FINANCIAL SOLUTIONS, INC. BR · Entity 3252 | GrantCommon Stock | 95 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-000248 · doc4.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,263 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 17, 2016 Filed Nov 18, 2016 11:59 UTC | BROADRIDGE FINANCIAL SOLUTIONS, INC. BR · Entity 3252 | GrantStock Option (Right to Buy) · Derivative | 6,777 | $0.00 Strike: $64.39 | $0.00 |
DisclosureSEC source: 0001225208-16-041966 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,777 Underlying: Common Stock · 6,777 shares Expires 2026-11-17 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 17, 2016 Filed Nov 18, 2016 11:59 UTC | BROADRIDGE FINANCIAL SOLUTIONS, INC. BR · Entity 3252 | GrantCommon Stock | 1,471 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-041966 · doc4.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,168 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 17, 2016 Filed Nov 29, 2016 17:05 UTC Amendment | BROADRIDGE FINANCIAL SOLUTIONS, INC. BR · Entity 3252 | GrantStock Option (Right to Buy) · Derivative | 6,777 | $0.00 Strike: $64.89 | $0.00 |
DisclosureSEC source: 0001225208-16-042356 · doc4a.xml · derivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,777 Underlying: Common Stock · 6,777 shares Expires 2026-11-17 F1 · derivative.exercise_price: This amendment is filed to correct the exercise price of the stock options to $64.89. F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 16, 2016 Filed Nov 17, 2016 10:42 UTC | BROADRIDGE FINANCIAL SOLUTIONS, INC. BR · Entity 3252 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $19.93 | $0.00 |
DisclosureSEC source: 0001225208-16-041920 · doc4.xml · derivative · entry 3 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2017-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2016 Filed Nov 17, 2016 10:42 UTC | BROADRIDGE FINANCIAL SOLUTIONS, INC. BR · Entity 3252 | SaleCommon Stock | 7,925 | $62.66 | $496,574.95 |
DisclosureSEC source: 0001225208-16-041920 · doc4.xml · nonDerivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,697 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.62 - $62.68, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| November 16, 2016 Filed Nov 17, 2016 10:42 UTC | BROADRIDGE FINANCIAL SOLUTIONS, INC. BR · Entity 3252 | Exercise / conversionCommon Stock | 12,500 | $19.93 | $249,125.00 |
DisclosureSEC source: 0001225208-16-041920 · doc4.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,622 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 18:38 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 1,338 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-16-004784 · es1601142_4-brun.xml · nonDerivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,513 F2 · shares: The reported transaction reflects the grant of Deferred Stock Units under the Issuer's 2014 Omnibus Award and represents a like number of shares of the Issuer's common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of the Issuer's common stock. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 18:38 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 2,587 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-16-004784 · es1601142_4-brun.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,175 F1 · shares: The reported transaction reflects the grant of Restricted Stock Units under the Issuer's 2014 Omnibus Award Plan and represents a like number of shares of the Issuer's common stock. These Restricted Stock Units vest in full at the earlier of November 15, 2017 or the Issuer's next annual meeting of stockholders. Upon vesting these Restricted Stock Units will be deferred and settled in shares of the Issuer's common stock 180 days after the date the Reporting Person ceases to be a member of the Issuers's board of directors. Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 22:54 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | Exercise / conversionRestricted Stock Units · Derivative | 4,128 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179706-16-000516 · edgar.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,128 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · shares: As previously reported, on 11/11/15 the reporting person was granted 4,078 restricted stock units ("RSUs"), all of which cliff vested on 11/11/16, at which time the vested shares were delivered to the reporting person. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 12.1897 dividend equivalent rights at $18.40 per RSU credited to the reporting person's account on 07/06/16, and 9.9818 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16. The number of derivative securities in column 5 includes 50 vested dividend equivalent rights and a de minimus adjustment of 0.1855 due to fractional rounding of the dividend equivalent rights. F2 · price: As previously reported, on 11/11/15 the reporting person was granted 4,078 restricted stock units ("RSUs"), all of which cliff vested on 11/11/16, at which time the vested shares were delivered to the reporting person. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 12.1897 dividend equivalent rights at $18.40 per RSU credited to the reporting person's account on 07/06/16, and 9.9818 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16. The number of derivative securities in column 5 includes 50 vested dividend equivalent rights and a de minimus adjustment of 0.1855 due to fractional rounding of the dividend equivalent rights. F2 · derivative.exercise_date: As previously reported, on 11/11/15 the reporting person was granted 4,078 restricted stock units ("RSUs"), all of which cliff vested on 11/11/16, at which time the vested shares were delivered to the reporting person. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 12.1897 dividend equivalent rights at $18.40 per RSU credited to the reporting person's account on 07/06/16, and 9.9818 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16. The number of derivative securities in column 5 includes 50 vested dividend equivalent rights and a de minimus adjustment of 0.1855 due to fractional rounding of the dividend equivalent rights. F2 · derivative.expiration_date: As previously reported, on 11/11/15 the reporting person was granted 4,078 restricted stock units ("RSUs"), all of which cliff vested on 11/11/16, at which time the vested shares were delivered to the reporting person. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 12.1897 dividend equivalent rights at $18.40 per RSU credited to the reporting person's account on 07/06/16, and 9.9818 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16. The number of derivative securities in column 5 includes 50 vested dividend equivalent rights and a de minimus adjustment of 0.1855 due to fractional rounding of the dividend equivalent rights. Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 22:54 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | Exercise / conversionCommon Stock | 4,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001179706-16-000516 · edgar.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,128 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 11:33 UTC | BROADRIDGE FINANCIAL SOLUTIONS, INC. BR · Entity 3252 | GrantCommon Stock | 85 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-039907 · doc4.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,122 F1 · security: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| July 06, 2016 Filed Nov 15, 2016 22:54 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | GrantRestricted Stock Units · Derivative | 55.2872 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179706-16-000516 · edgar.xml · derivative · entry 3 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,224.2872 Underlying: Common Stock · 55.2872 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F3 · shares: On 04/25/16 the reporting person was granted 10,169 RSUs, all of which will cliff vest on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The 55.2872 dividend equivalent rights being reported reflect 30.3965 dividend equivalent rights at $18.40 per RSU credited to the reporting person's account on 07/06/16, and 24.8907 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16. F3 · price: On 04/25/16 the reporting person was granted 10,169 RSUs, all of which will cliff vest on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The 55.2872 dividend equivalent rights being reported reflect 30.3965 dividend equivalent rights at $18.40 per RSU credited to the reporting person's account on 07/06/16, and 24.8907 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16. F3 · derivative.exercise_date: On 04/25/16 the reporting person was granted 10,169 RSUs, all of which will cliff vest on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The 55.2872 dividend equivalent rights being reported reflect 30.3965 dividend equivalent rights at $18.40 per RSU credited to the reporting person's account on 07/06/16, and 24.8907 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16. F3 · derivative.expiration_date: On 04/25/16 the reporting person was granted 10,169 RSUs, all of which will cliff vest on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The 55.2872 dividend equivalent rights being reported reflect 30.3965 dividend equivalent rights at $18.40 per RSU credited to the reporting person's account on 07/06/16, and 24.8907 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16. Read SEC document |
| May 27, 2016 Filed May 31, 2016 19:54 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 3,009.915 | $56.48 | $170,000.00 |
DisclosureSEC source: 0001225208-16-034164 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,714.139 Underlying: Common Stock · 3,009.915 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2015 Filed Jun 1, 2015 18:50 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 2,463.4587 | $60.89 | $150,000.00 |
DisclosureSEC source: 0001225208-15-013054 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,782.3837 Underlying: Common Stock · 2,463.4587 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 30, 2014 Filed Jun 3, 2014 16:59 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 2,592.4646 | $57.86 | $150,000.00 |
DisclosureSEC source: 0001225208-14-014278 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,599.9226 Underlying: Common Stock · 2,592.4646 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 31, 2013 Filed Jun 3, 2013 19:06 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 3,211.9914 | $46.70 | $150,000.00 |
DisclosureSEC source: 0001225208-13-013648 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,290.8604 Underlying: Common Stock · 3,211.9914 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 25, 2012 Filed May 29, 2012 19:22 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 3,994.6738 | $37.55 | $150,000.00 |
DisclosureSEC source: 0001225208-12-013298 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,432.5188 Underlying: Common Stock · 3,994.6738 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 27, 2011 Filed May 31, 2011 14:44 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 4,142.5021 | $36.21 | $150,000.00 |
DisclosureSEC source: 0001225208-11-015333 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,901.4675 Underlying: Common Stock · 4,142.5021 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2011 Filed Apr 1, 2011 12:58 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 473.3414 | $33.01 | $15,625.00 |
DisclosureSEC source: 0001225208-11-010578 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,676.8374 Underlying: Common Stock · 473.3414 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2010 Filed Jan 3, 2011 17:51 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 343.3685 | $36.04 | $12,375.00 |
DisclosureSEC source: 0001225208-11-000080 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,134.4058 Underlying: Common Stock · 343.3685 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| September 30, 2010 Filed Oct 1, 2010 21:03 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 376.9356 | $36.81 | $13,875.00 |
DisclosureSEC source: 0001225208-10-021731 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,725.3223 Underlying: Common Stock · 376.9356 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| August 04, 2010 Filed Aug 6, 2010 14:47 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $35.19 | $0.00 |
DisclosureSEC source: 0001225208-10-018694 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2020-08-03 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning August 4, 2011. Read SEC document |
| June 30, 2010 Filed Jul 1, 2010 18:10 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 332.4278 | $34.97 | $11,625.00 |
DisclosureSEC source: 0001225208-10-015965 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,285.3047 Underlying: Common Stock · 332.4278 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 28, 2010 Filed Jun 1, 2010 19:54 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 1,632.5319 | $33.69 | $55,000.00 |
DisclosureSEC source: 0001225208-10-014274 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,952.8769 Underlying: Common Stock · 1,632.5319 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2010 Filed Apr 2, 2010 16:11 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 125.502 | $37.35 | $4,687.50 |
DisclosureSEC source: 0001225208-10-009539 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,277.4599 Underlying: Common Stock · 125.502 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2009 Filed Jan 4, 2010 19:39 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 111.1795 | $36.54 Strike: $0.00 | $4,062.50 |
DisclosureSEC source: 0001225208-10-000135 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,111.6349 Underlying: Common Stock · 111.1795 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:31 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $24.30 | $0.00 |
DisclosureSEC source: 0001225208-09-021799 · doc4.xml · derivative · entry 3 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2019-04-30 F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:31 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 4,000.4554 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-021799 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000.4554 Underlying: Common Stock · 4,000.4554 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:31 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-021799 · doc4.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 F1 · price: Received in exchange for an equivalent number of shares of Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) ("MSD") common stock in connection with the completion of transactions contemplated by the Agreement and Plan of Merger by and among, inter alia, MSD and Merck & Co., Inc. (formerly Schering-Plough Corporation) (the "Transactions"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.